Page last updated: 2024-08-26

canthin-6-one and Neoplasms

canthin-6-one has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chadha, N; Silakari, O1
da Costa, WF; de Carvalho, JE; Foglio, MA; Garcia, FP; Leite Silva, CM; Meyer, E; Nakamura, CV; Rodrigues, JH; Ruiz, AL; Sarragiotto, MH; Ueda-Nakamura, T1

Reviews

1 review(s) available for canthin-6-one and Neoplasms

ArticleYear
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view.
    European journal of medicinal chemistry, 2017, Jul-07, Volume: 134

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Bacterial Infections; Chemistry, Pharmaceutical; Cholinergic Antagonists; Drug Discovery; Humans; Indoles; Migraine Disorders; Mycoses; Neoplasms; Virus Diseases

2017

Other Studies

1 other study(ies) available for canthin-6-one and Neoplasms

ArticleYear
Synthesis, antitumor, antitrypanosomal and antileishmanial activities of benzo[4,5]canthin-6-ones bearing the N'-(Substituted benzylidene)-carbohydrazide and N-Alkylcarboxamide groups at C-2.
    Chemical & pharmaceutical bulletin, 2012, Volume: 60, Issue:11

    Topics: Antineoplastic Agents; Benzylidene Compounds; Carbolines; Cell Line, Tumor; Chagas Disease; Humans; Indole Alkaloids; Indoles; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Naphthyridines; Neoplasms; Trypanocidal Agents; Trypanosoma cruzi

2012